WASHINGTON (AP) — The Supreme Court is being asked to reverse an appellate ruling that would cut off mail-order access to a drug used in the most common
Danco Laboratories, which manufactures mifepristone, filed an appeal Friday asking the Supreme Court to reverse the appellate court's limits on patient access to the drug.
The drug company Danco Laboratories has asked the Supreme Court to review the case challenging the legality of the abortion pill mifepristone. Danco’s request comes in response to a ruling by the U.S. Court of Appeals for the 5th Circuit that would impose major restrictions on how the medication is …
The Biden administration asked the US Supreme Court to uphold broad access to a widely used abortion pill, seeking a review of a ruling that would bar mail-order prescriptions and require in-person doctor visits.
Coming not even two years since the conservative supermajority overturned Roe v. Wade, the Supreme Court is being asked to jump into another major battle over abortion.
The Supreme Court is being asked to reverse an appellate ruling that would cut off mail-order access to a drug used in the most common method of abortion in the United States.
The Justice Department pressured the Supreme Court on Friday to reconsider the fate of mifepristone in the U.S. The abortion pill may be dramatically limited if the court decides not to review.
The Justice Department on Friday asked the Supreme Court to review a lower court ruling that limited access to the abortion pill mifepristone, calling that decision "unprecedented."
The Supreme Court is being asked to reverse an appellate ruling that would cut off mail-order access to a drug used in the most common method of abortion in the United States.
The manufacturer of a widely used abortion pill asked the US Supreme Court on Friday to toss out a lower court ruling that would restrict access to the drug.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
